S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7141 −0.01%
CLOSED · 03:25 ET
Market ClerkRecap
Sat Oct 24 · markets closed6 signals on Oct 2394 insider buys this week · $48.3MCIRO short report next: Oct 30The week ahead

AYTU

AYTU BIOPHARMA, INC
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
1.90
−0.08 −4.04%
USD · close Oct 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $20.4MP/E —DIV YIELD —FCF YIELD 8.06%REV TTM $56.6M −14.0%NET INCOME −$34.1M −2177.8%NET CASH $11.7M52W 1.90 – 2.90SEC XBRL · TTM TO Invalid Date

What AYTU had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 22Results announcedSep 22open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch AYTU. Know when insiders buy.
One email the day a filing lands. Free.